© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
HIV-positive people with low CD4 counts have poorer survival after a cancer diagnosis.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Liver cancer is a growing problem worldwide but new treatments show promise.
Retrovirus conference includes news on liver cancer and statins for cancer prevention.
Researchers urge clinicians to closely monitor their patients with HIV and chronic kidney disease.
Statin users were less likely to develop several types of cancer in a large study.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
